Clinical trials for treatments to prevent recurring strokes typically only include participants who have little to no disability from a prior stroke. A new Yale study finds that leaving patients with ...
In 2006, Kevin Sheth was a 27-year-old neurology resident in Boston, at both Massachusetts General Hospital and Brigham and Women’s Hospital. In that role, he did rotations within their neurology ...
It was 3 o’clock in the morning when Larry Christian awoke to sudden pain in his left hand and arm. He didn’t think much of it and managed to fall back asleep. The next day, he got up, and his wife ...
Asundexian reduced ischemic stroke risk without increasing major bleeding in the OCEANIC-STROKE study, meeting primary efficacy and safety endpoints. The study included 12,327 patients with acute ...
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal ...
According to Lin, whose research focuses on stroke recovery and rehabilitation, previous studies at UAB, like the REGARDS study, have looked at disparities regarding stroke care. This prompted him and ...
The role of endovascular therapy for acute stroke with a large infarction has not been extensively studied in differing populations. We conducted a multicenter, prospective, open-label, randomized ...
BARCELONA, Spain—Promising results from multiple phase II studies of oral factor XIa inhibitors presented here at the European Society of Cardiology Congress 2022 warrant moving on to phase III trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback